|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/24 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 1703893 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04815562.6 |
| Date of filing the European patent application | 2004-12-23 | |
| (97) | Date of publication of the European application | 2006-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2012-04-11 |
| (46) | Date of publication of the claims translation | 2012-07-25 |
| (86) | Number | PCT/US2004/043501 |
| Date | 2004-12-23 |
| (87) | Number | WO 2005/062967 |
| Date | 2005-07-14 |
| (30) | Number | Date | Country code |
| 532130 P | 2003-12-23 | US |
| (72) |
FUNG, Sek, Chung, US
MOYLE, Matthew, US
LU, Mason, GB
YAN, Changning, US
SINGH, Sanjaya, US
HUANG, Dan, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nauji anti-IL 13 antikūnai ir jų panaudojimas |
| NOVEL ANTI-IL 13 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-11-22 | 347.00 EUR |